Drug Discovery Partners International

Drug Discovery Partners (DDP) is a Tokyo-based biotechnology company specializing in the discovery and early-stage development of novel small molecule therapeutics. Founded by experienced pharmaceutical industry veterans, the company leverages a robust drug discovery platform that integrates structure-based drug design (SBDD) and fragment-based drug discovery (FBDD) to target challenging biological pathways. DDP focuses on high-unmet-need areas including oncology, central nervous system (CNS) disorders, and metabolic diseases. The company's business model centers on advancing internal programs to the pre-clinical or early clinical stage before establishing strategic partnerships or licensing agreements with global pharmaceutical companies. By bridging the gap between academic research and industrial application, DDP aims to accelerate the delivery of innovative medicines to patients.